Trials / Unknown
UnknownNCT03735134
Colchicine in Periprocedural Myocardial Infarction: the Role of Alpha Defensin
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this research is to study the effect of a loading dose of colchicine on the occurrence of periprocedural myocardial infarction (PPMI) in elective percutaneous coronary intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colchicine Loading Dose | Two milligrams of colchicine will be administrated in addition to the standard of care treatment |
| DRUG | Standard of care treatment prior to elective PCI | All medications normally given to patients prior to elective PCI |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
- First posted
- 2018-11-08
- Last updated
- 2018-11-08
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03735134. Inclusion in this directory is not an endorsement.